This is an excerpt from Crashing Excel to Curing Cancer — How AI and Open Science Are Rewiring Drug Discovery(Part 5/6). In this episode, host René Bastón, Venture Partner at Covenant Venture Capital, sits down with Tommy Tang, Director of Bioinformatics at AstraZeneca. Large language models and machine learning promise to revolutionize drug development—but what does it take to make that real? In this episode, we explore the critical role of domain expertise, data quality, and infrastructure. From messy datasets to organizational data silos, we break down why AI alone isn’t enough—and what must change to truly accelerate breakthroughs in cancer research. Tune in for valuable insights on: Overcoming challenges in data science Embracing AI in healthcare Leveraging technology to revolutionize healthcare You can connect with our host, René Bastón, on LinkedIn: https://www.linkedin.com/in/renebaston/ And our guest, Tommy Tang, on LinkedIn: https://www.linkedin.com/in/🎯-ming-tommy-tang-40650014/ For more information on any of the topics discussed, visit the Hill Research Podcast at https://www.hillresearch.ai/podcast.